Helei Hou
Impact in
- Health Informatics top 2%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
-
- Lung Cancer Treatments and Mutations 17
- Gastric Cancer Management and Outcomes 9
- Oncology 29
- Cancer Immunotherapy and Biomarkers 7
- Peptidase Inhibition and Analysis 7
- Cancer Cells and Metastasis 5
- Co-authors
- Xiaochun Zhang (11 shared papers)Dantong Sun (18 shared papers)Man Jiang (17 shared papers)Chao Ge (9 shared papers)Liang Yu (2 shared papers)Kang Qin (1 shared paper)Chuantao Zhang (21 shared papers)Hong Li (8 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Oncotarget (3 papers)The Oncologist (3 papers)Scientific Reports (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Helei Hou
64 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 103
- Health Informatics 50
- Cancer Research 288
- Oncology 494
- Pulmonary and Respiratory Medicine 428
- Pathology and Forensic Medicine 167
Countries citing papers authored by Helei Hou
This map shows the geographic impact of Helei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helei Hou more than expected).
Fields of papers citing papers by Helei Hou
This network shows the impact of papers produced by Helei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helei Hou. The network helps show where Helei Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Helei Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 103 | |
| 2 | 2018 | 86 | |
| 3 | 2012 | 82 | |
| 4 | 2018 | 56 | |
| 5 | 2012 | 50 | |
| 6 | 2013 | 48 | |
| 7 | 2019 | 44 | |
| 8 | 2012 | 43 | |
| 9 | 2020 | 42 | |
| 10 | 2014 | 40 | |
| 11 | 2001 | 39 | |
| 12 | 2018 | 38 | |
| 13 | 2021 | 33 | |
| 14 | 2021 | 32 | |
| 15 | 2020 | 24 | |
| 16 | 2018 | 22 | |
| 17 | 2017 | 21 | |
| 18 | 2015 | 21 | |
| 19 | 2018 | 20 | |
| 20 | 2019 | 20 |
About Helei Hou
Helei Hou is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 72 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Cancer Genomics and Diagnostics (9 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer Mechanisms and Therapy (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Chromatin Remodeling and Cancer (7 papers), Peptidase Inhibition and Analysis (7 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Health Informatics (50 citations), Cancer Research (288 citations), Oncology (494 citations), Pulmonary and Respiratory Medicine (428 citations) and Pathology and Forensic Medicine (167 citations). Helei Hou has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xiaochun Zhang, Dantong Sun, Man Jiang, Chao Ge, Liang Yu, Kang Qin, Chuantao Zhang, Hong Li, Na Zhou and Jinjun Li. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, The Oncologist, Scientific Reports and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.